Eli Lilly & Co., US5324571083

Lam Research clears fresh record high, shares extend semiconductor rally

Published on 06/29/2026 at 20:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research benefits from the latest semiconductor strength, with shares touching a new high on NASDAQ as investors digest robust industry spending plans and recent analyst commentary on equipment makers.

Eli Lilly & Co., US5324571083, Illustration mit AI erstellt.
Eli Lilly & Co., US5324571083, Illustration mit AI erstellt.

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-29, 20:41.

Lam Research (US5324571083) shares touched a fresh record high on NASDAQ in Monday trading, supported by continued optimism on wafer fabrication equipment demand as sector peers like Applied Materials and KLA remain in favor with US investors. The move aligns with recent positive commentary on chip equipment capital spending in reports from major brokers and market outlets.

New high in an active NASDAQ session

Lam Research trades on NASDAQ under the ticker LRCX, and intraday data from major quote services showed the stock edging to a new 52-week and all-time high zone during Monday's US session as semiconductor names collectively advanced. The stock participates in the broader S&P 500 technology cohort, where chipmakers and equipment providers continue to attract capital inflows.

Sector peers such as Applied Materials and KLA have also enjoyed robust demand signals from foundry and logic customers, reinforcing the market narrative that equipment spending remains resilient across advanced nodes and specialty technologies. Recent market commentary in US financial media has highlighted sustained orders and long lead times for critical deposition, etch and inspection tools, which underpin Lam Research's positioning in the supply chain.

Monday focus on technical picture

From a technical perspective, Lam Research shares now trade clearly above commonly watched moving averages, including the 200-day line referenced in many chart-based analyses, underscoring the strength of the current uptrend. Traders monitoring NASDAQ-100 constituents have pointed to semiconductor equipment suppliers as notable contributors to index performance in recent weeks.

Analyst reports from large international houses have repeatedly noted that equipment suppliers benefit from secular themes such as high-performance computing, artificial intelligence accelerators and advanced memory, which together drive multi-year fab expansions. This backdrop provides context for the new share-price high, even as individual broker recommendations and price targets vary across the coverage universe.

Go deeper

All news and analysis on the Lam Research shares

How Lam Research trades on NASDAQ and responds to semiconductor capital spending trends is documented in the ongoing coverage and company disclosures.

How Lam Research earns its money

Lam Research generates its revenue primarily by supplying wafer fabrication equipment, notably plasma etch and deposition systems, to semiconductor manufacturers around the world. The company also provides related services, spares and process support, forming a recurring revenue stream tied to fab utilization and technology upgrades.

Where the stock trades today

Lam Research shares trade on NASDAQ under the ticker LRCX, with the latest observed price in Monday US trading quoted in US dollars on the exchange data feeds.

Lam Research at a glance

  • Company: Lam Research Corporation
  • ISIN: US5324571083
  • WKN: 869596
  • Ticker: LRCX
  • Trading venue: NASDAQ
  • Price (as of 2026-06-29, 20:30): 980.00 USD
  • Market cap: 129.0 billion USD (as of 2026-06-29)
  • Sector / industry: Semiconductor equipment and materials
  • Index membership: S&P 500, NASDAQ-100
  • Next earnings date: not officially scheduled

More on the Lam Research shares in social media

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US5324571083 | ELI LILLY & CO. | boerse | 69655001 | bgmi